JACN
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hontecillas, R.
Right arrow Articles by Bassaganya-Riera, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hontecillas, R.
Right arrow Articles by Bassaganya-Riera, J.
Journal of the American College of Nutrition, Vol. 28, No. 2, 184-195 (2009)
Published by the American College of Nutrition

Activation of PPAR {gamma} and {alpha} by Punicic Acid Ameliorates Glucose Tolerance and Suppresses Obesity-Related Inflammation

Raquel Hontecillas, DVM, PhD, Marianne O'Shea, PhD, Alexandra Einerhand, PhD, Margaret Diguardo, BA and Josep Bassaganya-Riera, DVM, PhD

Laboratory of Nutritional Immunology & Molecular Nutrition, Virginia Bioinformatics Institute, Virginia Tech (R.H., J.B.-R.)
Nutrition Therapeutics Inc (M.D.), Blacksburg, Virginia
Lipid Nutrition BV (M.O., A.E.), Channahon, Illinois

Address reprint requests to: Josep Bassaganya-Riera, Laboratory of Nutritional Immunology & Molecular Nutrition, Virginia Bioinformatics Institute, Virginia Tech, 1 Washington Street, Blacksburg, VA 24061. E-mail: jbassaga{at}vt.edu

Objective: Peroxisome proliferator-activated receptor {gamma} (PPAR {gamma}) is the molecular target for thiazolidinediones (TZDs), a class of synthetic antidiabetic agents. However, the naturally occurring agonists of PPARs remain largely unknown. Punicic acid (PUA) is a conjugated linolenic acid isomer found in pomegrante. The objective of this study was to test the hypothesis that PUA activates PPAR {gamma} and thereby ameliorates glucose homeostasis and obesity-related inflammation.

Methods: The ability of PUA to modulate PPAR reporter activity was determined in 3T3-L1 pre-adipocytes. A cell-free assay was used to measure PUA's binding to the ligand-binding domain (LBD) of human PPAR {gamma}. The preventive actions of PUA were investigated using genetically obese db/db mice and a model of diet-induced obesity in PPAR {gamma}-expressing and tissue-specific PPAR {gamma} null mice. Expression of PPAR {alpha}, {gamma}, PPAR-responsive genes and TNF-{alpha} was measured in tissues controlling glucose homeostasis.

Results: PUA caused a dose-dependent increase PPAR {alpha} and {gamma} reporter activity in 3T3-L1 cells and bound although weakly to the LBD of human PPAR {gamma}. Dietary PUA decreased fasting plasma glucose concentrations, improved the glucose-normalizing ability, suppressed NF-{kappa}B activation, TNF-{alpha} expression and upregulated PPAR {alpha}- and {gamma}-responsive genes in skeletal muscle and adipose tissue. Loss of PPAR {gamma} impaired the ability of dietary PUA to improve glucose homeostasis and suppress inflammation.

Conclusions: Our studies demonstrate that PUA binds and robustly activates PPAR {gamma}, increases PPAR {gamma}-responsive gene expression and the loss of PPAR {gamma} in immune cells impairs its ability to ameliorate diabetes and inflammation.

Key words: punicic acid, TNF-{alpha}, obesity, inflammation, PPAR alpha, PPAR gamma

Abbreviations: CLA = conjugated linoleic acid • LBD = ligand-binding domain • PPAR = peroxisome proliferator-activated receptor • PUA = punicic acid • WAT = white adipose tissue







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the American College of Nutrition.